Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Dabigatran 220mg	1,010
Overall Study	STARTED	Enoxaparin	1,003
Overall Study	COMPLETED	Dabigatran 220mg	895
Overall Study	COMPLETED	Enoxaparin	910
Overall Study	NOT COMPLETED	Dabigatran 220mg	115
Overall Study	NOT COMPLETED	Enoxaparin	93
Treatment	STARTED	Dabigatran 220mg	1,010
Treatment	STARTED	Enoxaparin	1,003
Treatment	COMPLETED	Dabigatran 220mg	903
Treatment	COMPLETED	Enoxaparin	906
Treatment	NOT COMPLETED	Dabigatran 220mg	107
Treatment	NOT COMPLETED	Enoxaparin	97

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00657150/flow